scispace - formally typeset
S

Silvia Maestroni

Researcher at Vita-Salute San Raffaele University

Publications -  20
Citations -  1278

Silvia Maestroni is an academic researcher from Vita-Salute San Raffaele University. The author has contributed to research in topics: Diabetic nephropathy & Diabetes mellitus. The author has an hindex of 13, co-authored 20 publications receiving 1168 citations. Previous affiliations of Silvia Maestroni include Brigham and Women's Hospital & Harvard University.

Papers
More filters
Journal ArticleDOI

Local Activation or Implantation of Cardiac Progenitor Cells Rescues Scarred Infarcted Myocardium Improving Cardiac Function

TL;DR: Clinically, CPCs represent an ideal candidate cell for cardiac repair in patients with chronic heart failure and may be isolated from myocardial biopsies and, following their expansion in vitro, administered back to the same patients avoiding the adverse effects associated with the use of nonautologous cells.
Journal ArticleDOI

New susceptibility loci associated with kidney disease in type 1 diabetes.

Niina Sandholm, +105 more
- 20 Sep 2012 - 
TL;DR: A meta-analysis of genome-wide association studies of T1D DN revealed association of two SNPs with ESRD in the AFF3 gene and an intergenic SNP on chromosome 15q26 between the genes RGMA and MCTP2, which represent new signals in the pathogenesis of DN.
Journal ArticleDOI

Genome-Wide Association Study of Diabetic Kidney Disease Highlights Biology Involved in Glomerular Basement Membrane Collagen.

Rany M. Salem, +97 more
TL;DR: In this paper, a large collection of type 1 diabetes cohorts with harmonized diabetic kidney disease phenotypes were assembled through collaboration with the Diabetes Nephropathy Collaborative Research Initiative, and 16 genome-wide significant risk loci were identified.
Journal ArticleDOI

The Role of Angiogenesis in the Development of Proliferative Diabetic Retinopathy: Impact of Intravitreal Anti-VEGF Treatment

TL;DR: The different antiangiogenic approaches used to treat proliferative diabetic retinopathy along with the respective advantages and limitations when compared to laser treatment are described.